TABLE 10.

PFS prediction at 6 months by LIPI, mLIPI, and EPSILoN scores

Predictive models	AUC (95% CI)	C‐index(95% CI)	Spearman rank correlation (p value)	H–L test (p value)
LIPI	0.642 (0.590–0.694)	0.627 (0.611–6.643)	−0.355 (<0.001)	6.142 (0.631)
mLIPI	0.720 (0.675–0.762)	0.677 (0.652–0.682)	−0.560 (<0.001)	7.982 (0.435)
EPSILoN	0.633 (0.585–0.679)	0.631 (0.617–0.645)	−0.369 (<0.001)	4.333 (0.826)

Abbreviations: EPSILoN, Eastern Cooperative Oncology Group performance status, smoking, liver metastases, lactate dehydrogenase, neutrophil‐to‐lymphocyte ratio; LIPI, lung immune prognostic index; mLIPI, modified lung immune predictive index; PFS, progression‐free survival.